Ipilimumab, CAS 477202-00-9

Description: Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.

CAS Number: 477202-00-9

Molecular Weight: 148 kDa

References: Hu-Lieskovan S, et al. Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges. J Clin Oncol. 2014 Jul 20;32(21):2248-54.

• SKU: TGMT9906-5mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T9906-5mg
• Package Unit: 5 mg
• Quantity Unit: STK